| 1599 - 1599 |
Poly(2-oxazoline)s and Related Pseudo-Polypeptides
Schlaad H, Hoogenboom R |
| 1600 - 1612 |
How to Modulate the Chemical Structure of Polyoxazolines by Appropriate Functionalization
Guillerm B, Monge S, Lapinte V, Robin JJ |
| 1613 - 1631 |
Poly(2-oxazoline)s as Polymer Therapeutics
Luxenhofer R, Han YC, Schulz A, Tong J, He ZJ, Kabanov AV, Jordan R |
| 1632 - 1647 |
Strategies for the Synthesis of Poly(2-Oxazoline)-Based Hydrogels
Kelly AM, Wiesbrock F |
| 1648 - 1662 |
Poly(2-Oxazoline)s - Are They More Advantageous for Biomedical Applications Than Other Polymers?
Sedlacek O, Monnery BD, Filippov SK, Hoogenboom R, Hruby M |
| 1663 - 1676 |
Polyoxazolines for Nonfouling Surface Coatings - A Direct Comparison to the Gold Standard PEG
Konradi R, Acikgoz C, Textor M |
| 1677 - 1682 |
Well-Defined Amphiphilic Poly(2-oxazoline) ABA-Triblock Copolymers and Their Aggregation Behavior in Aqueous Solution
Krumm C, Fik CP, Meuris M, Dropalla GJ, Geltenpoth H, Sickmann A, Tiller JC |
| 1683 - 1689 |
Thermoresponsive Nanoparticles Based on Poly(2-alkyl-2-Oxazolines) and Pluronic F127
Panek J, Filippov SK, Hruby M, Rabyk M, Bogomolova A, Kucka J, Stepanek P |
| 1690 - 1694 |
Hofmeister Salt Effects on the LCST Behavior of Poly(2-Oxazoline) Star Ionomers
ten Brummelhuis N, Secker C, Schlaad H |
| 1695 - 1700 |
Poly(2-oxazoline) Hydrogel Monoliths via Thiol-ene Coupling
Dargaville TR, Forster R, Farrugia BL, Kempe K, Voorhaar L, Schubert US, Hoogenboom R |
| 1701 - 1707 |
Poly(2-ethyl-2-oxazoline) as Matrix Excipient for Drug Formulation by Hot Melt Extrusion and Injection Molding
Claeys B, Vervaeck A, Vervaet C, Remon JP, Hoogenboom R, De Geest BG |
| 1708 - 1713 |
Highly Defined Multiblock Copolypeptoids: Pushing the Limits of Living Nucleophilic Ring-Opening Polymerization
Fetsch C, Luxenhofer R |
| 1714 - 1719 |
Living Polymerization of N-Substituted beta-Alanine N-Carboxyanhydrides: Kinetic Investigations and Preparation of an Amphiphilic Block Copoly-beta-Peptoid
Grossmann A, Luxenhofer R |
